Ocata Therapeutics., prices its public offering of 5.5 Million shares of common stock and warrants to purchase an aggregate of 2.75 Million shares of common stock at $5.50 per share and accompanying warrant at $7.48.
Closing is on 22nd June 2015.
View the full release here.